Mizuho Securities Co. Ltd. Biogen Inc. Transaction History

Mizuho Securities Co. Ltd.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$194.69 - $268.46 $747,609 - $1.03 Million	3,840 New	3,840 $921,000
Q4 2021 Feb 04, 2022	SELL	$223.92 - $287.77 $6,717 - $8,633	-30 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$282.99 - $369.05 $8,489 - $11,071	30 New	30 $8,000
Q2 2021 Aug 05, 2021	SELL	$259.0 - $414.71 $129,500 - $207,355	-500 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$242.95 - $284.63 $145,770 - $170,778	-600 Reduced 54.55%	500 $140,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $94,504 - $142,252	400 Added 57.14%	1,100 $269,000
Q3 2020 Nov 04, 2020	SELL	$264.77 - $305.71 $556,017 - $641,991	-2,100 Reduced 75.0%	700 $199,000
Q2 2020 Aug 04, 2020	BUY	$258.66 - $342.55 $120,535 - $159,628	466 Added 19.97%	2,800 $886,000
Q1 2020 Apr 21, 2020	SELL	$268.85 - $341.04 $241,158 - $305,912	-897 Reduced 27.76%	2,334 $738,000
Q4 2019 Feb 07, 2020	BUY	$220.06 - $304.07 $711,013 - $982,450	3,231 New	3,231 $959,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $43,488 - $48,776	-200 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$219.29 - $241.72 $43,858 - $48,344	200 New	200 $47,000
Q1 2019 May 08, 2019	SELL	$216.71 - $338.96 $21,671 - $33,896	-100 Closed	0 $0
Q4 2018 Feb 13, 2019	BUY	$278.5 - $352.75 $27,850 - $35,275	100 New	100 $30,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Mizuho Securities Co. Ltd., based on Form 13F filings with the SEC.

Stay updated on Mizuho Securities Co. Ltd. with notifications on news.